Skip to content
GB Pharma
  • Who we are
    • Our History
    • Why choose us
  • Rare disease
  • Global coverage
  • clinical and observational research
    • observational studies
    • rwe
    • pass/paes
    • Services
    • International coverage
  • Medical devices
    • Pre-market clinical studies
    • Post-market clinical studies
    • Marketing surveys
    • Regulatory affairs
    • Vigilance and Surveillance
  • PSP & post marketing services
    • Patient support program
    • Marketing survey
  • Regulatory affairs
  • Pharmacovigilance
  • We Share | Blog
  • Contacts
    • Work with us

Blog

Description: Explore insightful content on diverse topics such as clinical research, medical devices, marketing services, regulatory affairs, and pharmacovigilance on the GB Pharma blog. Find out who we are, why you should choose us, and how to get in touch. Discover our commitment to ethics, anti-corruption, privacy, and gender equality through our UNI/Pdr 125:2020 certification. Stay informed and engaged with whistleblowing policies embedded into our practices.

Categories Blog Leave a comment

COMPLIANCE INSIGHTS | Understanding the Regulatory Landscape: the Impact of MDR 2017/745 on Medical Devices

8 March 202423 February 2024 by artecosw

As the medical device industry continues to evolve, so too do the regulatory frameworks governing these critical products.

GB Pharma s.r.l.

Via Cesare Ferreri, 11 – 27100 Pavia – Italy
Tel: +39.0382.530059
E-mail: info@gbpharma.it
Partita IVA: 02183430186

Services

  • Global coverage
  • Clinical research
  • Medical devices
  • Marketing Services
  • Regulatory affairs
  • Pharmacovigilance and Drug Safety

Who we are

  • Who we are
  • Why choose us
  • Contacts
  • Work with us

Policy

  • Ethical code
  • Anti-corruption
  • Privacy and Cookie
  • Privacy information
  • Equal Opportunities
  • UNI/Pdr 125:2020 management system certification for gender equality
  • Whistleblowing


      

Design by GSite Web Agency

© 2025 GB Pharma